Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jan Volavka

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Procedures

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nolan Karen A; Shope Constance B; Citrome Leslie; Volavka Jan
Staff and patient views of the reasons for aggressive incidents: a prospective, incident-based study.
Volavka Jan; Citrome Leslie
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
Lindenmayer Jean-Pierre; Liu-Seifert Hong; Kulkarni Pandurang M; Kinon Bruce J; Stauffer Virginia; Edwards Sara E; Chen Lei; Adams David H; Ascher-Svanum Haya; Buckley Peter F; Citrome Leslie; Volavka Jan
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jan Volavka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nolan Karen A; Shope Constance B; Citrome Leslie; Volavka Jan
Staff and patient views of the reasons for aggressive incidents: a prospective, incident-based study.
The Psychiatric quarterly 2009;80(3):167-72.
2009: Volavka Jan; Citrome Leslie
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
Expert opinion on pharmacotherapy 2009;10(12):1917-28.
2009: Lindenmayer Jean-Pierre; Liu-Seifert Hong; Kulkarni Pandurang M; Kinon Bruce J; Stauffer Virginia; Edwards Sara E; Chen Lei; Adams David H; Ascher-Svanum Haya; Buckley Peter F; Citrome Leslie; Volavka Jan
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
The Journal of clinical psychiatry 2009;70(7):990-6.
2009: Lieberman Jeffrey A; Papadakis Kelly; Csernansky John; Litman Robert; Volavka Jan; Jia Xinwei Daniel; Gage Allyson;
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(5):1322-9.
2009: Volavka Jan; Citrome Leslie
All antipsychotics are equal, but some are more equal than others.
The Journal of clinical psychiatry 2009;70(3):429-30.
2009: Liu-Seifert Hong; Kinon Bruce J; Tennant Christopher J; Sniadecki Jennifer; Volavka Jan
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone.
Neuropsychiatric disease and treatment 2009;5():47-54.
2008: Volavka Jan; Nolan Karen A
Methodological structure for aggression research.
The Psychiatric quarterly 2008;79(4):293-300.
2008: Kinon Bruce J; Volavka Jan; Stauffer Virginia; Edwards Sara E; Liu-Seifert Hong; Chen Lei; Adams David H; Lindenmayer Jean-Pierre; McEvoy Joseph P; Buckley Peter F; Lieberman Jeffrey A; Meltzer Herbert Y; Wilson Daniel R; Citrome Leslie
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
Journal of clinical psychopharmacology 2008;28(4):392-400.
2008: Volavka J; Citrome L
Heterogeneity of violence in schizophrenia and implications for long-term treatment.
International journal of clinical practice 2008;62(8):1237-45.
2008: Swanson Jeffrey W; Swartz Marvin S; Van Dorn Richard A; Volavka Jan; Monahan John; Stroup T Scott; McEvoy Joseph P; Wagner H Ryan; Elbogen Eric B; Lieberman Jeffrey A;
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.
The British journal of psychiatry : the journal of mental science 2008;193(1):37-43.
2008: Volavka Jan
Are all antipsychotics equal?
Lancet 2008;372(9634):201-2; author reply 202.
2007: Goff Donald C; Keefe Richard; Citrome Leslie; Davy Katherine; Krystal John H; Large Charles; Thompson Thomas R; Volavka Jan; Webster Elizabeth L
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
Journal of clinical psychopharmacology 2007;27(6):582-9.
2007: Citrome Leslie; Shope Constance B; Nolan Karen A; Czobor Pal; Volavka Jan
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.
International clinical psychopharmacology 2007;22(6):356-62.
2007: De Luca Vincenzo; Müller Daniel J; Hwang Rudi; Lieberman Jeffrey A; Volavka Jan; Meltzer Herbert Y; Kennedy James L
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
Human psychopharmacology 2007;22(7):463-7.
2006: Zai Gwyneth; Müller Daniel J; Volavka Jan; Czobor Pal; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.
Psychopharmacology 2006;188(2):171-82.
2006: Tiihonen Jari; Wahlbeck Kristian; Lönnqvist Jouko; Klaukka Timo; Ioannidis John P A; Volavka Jan; Haukka Jari
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
BMJ (Clinical research ed.) 2006;333(7561):224.
2006: Nolan Karen A; Czobor Pál; Citrome Leslie L; Krakowski Menachem; Lachman Herbert M; Kennedy James L; Ni Xingqun; Lieberman Jeffrey; Chakos Miranda; Volavka Jan
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
Journal of clinical psychopharmacology 2006;26(3):338-40.
2006: Citrome Leslie; Volavka Jan; Czobor Pal; Brook Shlomo; Loebel Antony; Mandel Francine S
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.
The Journal of clinical psychiatry 2006;67(4):638-42.
2006: Nolan Karea A; Volavka Jan
Video recording in the assessment of violent incidents in psychiatric hospitals.
Journal of psychiatric practice 2006;12(1):58-63.
2006: Hoptman Matthew J; Volavka Jan; Czobor Pál; Gerig Guido; Chakos Miranda; Blocher Joseph; Citrome Leslie L; Sheitman Brain; Lindenmayer Jean-Pierre; Lieberman Jeffrey A; Bilder Robert M
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(4):509-15.
2005: Volavka Jan; Czobor Pal; Citrome Leslie; McQuade Robert D; Carson William H; Kostic Dusan; Hardy Sterling; Marcus Ronald
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies.
The Journal of clinical psychiatry 2005;66(11):1362-6.
2005: Hoptman Matthew J; Volavka Jan; Weiss Elisabeth M; Czobor Pál; Szeszko Philip R; Gerig Guido; Chakos Miranda; Blocher Joseph; Citrome Leslie L; Lindenmayer Jean-Pierre; Sheitman Brian; Lieberman Jeffrey A; Bilder Robert M
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
Psychiatry research 2005;140(2):133-45.
2005: Müller Daniel J; De Luca Vincenzo; Sicard Tricia; King Nicole; Hwang Rudi; Volavka Jan; Czobor Pal; Sheitman Brian B; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Lieberman Jeffrey A; Meltzer Herbert Y; Kennedy James L
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):525-31.
2005: Citrome Leslie; Volavka Jan
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.
The Journal of clinical psychiatry 2005;66(8):1073-4.
2005: Bitter Istvan; Czobor Pal; Dossenbach Martin; Volavka Jan
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
European psychiatry : the journal of the Association of European Psychiatrists 2005;20(5-6):403-8.
2005: Volavka Jan; Nolan Karen A; Kline Linda; Czobor Pal; Citrome Leslie; Sheitman Brian; Lindenmayer Jean-Pierre; McEvoy Joseph; Lieberman Jeffrey A
Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Schizophrenia research 2005;76(1):127-9.
2005: Pomara Nunzio; Volavka Jan; Czobor P'al; Hernando Raymundo; Sidtis John J
Screaming and physical aggression in nursing homes.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(6):539-40.
2005: Müller Daniel J; Klempan Tim A; De Luca Vincenzo; Sicard Tricia; Volavka Jan; Czobor Pal; Sheitman Brian B; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Lieberman Jeffrey A; Honer William G; Kennedy James L
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Neuroscience letters 2005;379(2):81-9.
2005: De Luca Vincenzo; Vincent John B; Müller Daniel J; Hwang Rudi; Shinkai Takahiro; Volavka Jan; Czobor Pal; Sheitman Brian B; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Lieberman Jeffrey A; Kennedy James L
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment.
Pharmacological research : the official journal of the Italian Pharmacological Society 2005;51(4):381-4.
2005: Nolan Karen A; Volavka Jan; Czobor Pal; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie L; McEvoy Joseph; Lieberman Jeffrey A
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
Journal of psychiatric research 2005;39(1):109-15.
2005: Yates Kathy; Kunz Michal; Czobor Pal; Rabinowitz Steve; Lindenmayer Jean-Pierre; Volavka Jan
A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the program.
The journal of the American Academy of Psychiatry and the Law 2005;33(2):214-22.
2004: Volavka Jan; Bilder Robert; Nolan Karen
Catecholamines and aggression: the role of COMT and MAO polymorphisms.
Annals of the New York Academy of Sciences 2004;1036():393-8.
2004: Bilder Robert M; Volavka Jan; Lachman Herbert M; Grace Anthony A
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(11):1943-61.
2004: Citrome Leslie; Volavka Jan
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Postgraduate medicine 2004;116(4):49-51, 55-9, 63.
2004: Citrome Leslie; Volavka Jan
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.
Diabetes care 2004;27(8):2087-8; author reply 2089-90.
2004: Kunz Michael; Yates Kathy F; Czobor Pal; Rabinowitz Steve; Lindenmayer Jean-Pierre; Volavka Jan
Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral program.
Psychiatric services (Washington, D.C.) 2004;55(6):654-9.
2004: Volavka Jan; Bilder Robert M; Lachman Herbert M
Genetic linkage for schizophrenia?
The American journal of psychiatry 2004;161(6):1134-5; author reply 1135-6.
2004: Volavka Jan; Kennedy James L; Ni Xingqun; Czobor Pal; Nolan Karen; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph; Lieberman Jeffrey A
COMT158 polymorphism and hostility.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;127B(1):28-9.
2004: Volavka Jan; Czobor Pal; Nolan Karen; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Cooper Thomas B; Lieberman Jeffrey A
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.
Journal of clinical psychopharmacology 2004;24(2):225-8.
2004: Lindenmayer Jean-Pierre; Czobor Pal; Volavka Jan; Lieberman Jeffrey A; Citrome Leslie; Sheitman Brian; McEvoy Joseph P; Cooper Thomas B; Chakos Miranda
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
The Journal of clinical psychiatry 2004;65(4):551-6.
2004: Volavka Jan; Citrome Leslie
Olanzapine vs haloperidol for treatment of schizophrenia.
JAMA : the journal of the American Medical Association 2004;291(9):1064; author reply 1065-6.
2004: Nolan Karen A; Bilder Robert M; Lachman Herbert M; Volavka Jan
Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.
The American journal of psychiatry 2004;161(2):359-61.
2004: Volavka Jan; Czobor Pal; Cooper Thomas B; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Lieberman Jeffrey A
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
The Journal of clinical psychiatry 2004;65(1):57-61.
2003: Volavka Jan
Clozapine may be more effective than olanzapine for reducing suicidal behaviour in people with schizophrenia at high risk.
Evidence-based mental health 2003;6(3):93.
2003: Nolan Karen A; Czobor Pál; Roy Biman B; Platt Meredith M; Shope Constance B; Citrome Leslie L; Volavka Jan
Characteristics of assaultive behavior among psychiatric inpatients.
Psychiatric services (Washington, D.C.) 2003;54(7):1012-6.
2003: Fleischhacker W Wolfgang; Czobor Pal; Hummer Martina; Kemmler Georg; Kohnen Ralf; Volavka Jan
Placebo or active control trials of antipsychotic drugs?
Archives of general psychiatry 2003;60(5):458-64.
2003: Lindenmayer Jean-Pierre; Czobor Pal; Volavka Jan; Citrome Leslie; Sheitman Brian; McEvoy Joseph P; Cooper Thomas B; Chakos Miranda; Lieberman Jeffrey A
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
The American journal of psychiatry 2003;160(2):290-6.
2002: Mohr Pavel; Volavka Jan
Ladislav Haskovec and akathisia: 100th anniversary.
The British journal of psychiatry : the journal of mental science 2002;181():537.
2002: Lindenmayer Jean-Pierre; Czobor Pal; Volavka Jan; Lieberman Jeffrey A; Citrome Leslie; Sheitman Brian; Chakos Miranda; McEvoy Joseph P
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
The Journal of clinical psychiatry 2002;63(10):931-5.
2002: Bilder Robert M; Volavka Jan; Czobor Pál; Malhotra Anil K; Kennedy James L; Ni Xingqun; Goldman Robert S; Hoptman Matthew J; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Kunz Michal; Chakos Miranda; Cooper Thomas B; Lieberman Jeffrey A
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Biological psychiatry 2002;52(7):701-7.
2002: Citrome Leslie; Volavka Jan
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
Harvard review of psychiatry 2002;10(5):280-91.
2002: Citrome Leslie; Bilder Robert M; Volavka Jan
Managing treatment-resistant schizophrenia: evidence from randomized clinical trials.
Journal of psychiatric practice 2002;8(4):205-15.
2002: Hoptman Matthew J; Volavka Jan; Johnson Glyn; Weiss Elisabeth; Bilder Robert M; Lim Kelvin O
Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study.
Biological psychiatry 2002;52(1):9-14.
2002: Bilder Robert M; Goldman Robert S; Volavka Jan; Czobor Pal; Hoptman Matthew; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph; Kunz Michal; Chakos Miranda; Cooper Thomas B; Horowitz Terri L; Lieberman Jeffrey A
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
The American journal of psychiatry 2002;159(6):1018-28.
2002: Czobor Pál; Volavka Jan; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph; Cooper Thomas B; Chakos Miranda; Lieberman Jeffrey A
Antipsychotic-induced weight gain and therapeutic response: a differential association.
Journal of clinical psychopharmacology 2002;22(3):244-51.
2002: Volavka Jan
Risk for individuals with schizophrenia who are living in the community.
Psychiatric services (Washington, D.C.) 2002;53(4):484-5; author reply 485.
2002: Volavka Jan; Czobor Pal; Sheitman Brian; Lindenmayer Jean-Pierre; Citrome Leslie; McEvoy Joseph P; Cooper Thomas B; Chakos Miranda; Lieberman Jeffrey A
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
The American journal of psychiatry 2002;159(2):255-62.
2002: Citrome Leslie; Volavka Jan
Atypical antipsychotics: revolutionary or incremental advance?
Expert review of neurotherapeutics 2002;2(1):69-88.
2001: Citrome L; Krakowski M; Greenberg W M; Andrade E; Volavka J
Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
The Journal of clinical psychiatry 2001;62(11):901.
2001: Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer J P; McEvoy J; Cooper T B; Chakos M; Lieberman J A
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Psychiatric services (Washington, D.C.) 2001;52(11):1510-4.
2001: Lindenmayer J P; Volavka J; Lieberman J; Sheitman B; Citrome L; Chakos M; Czobor P; Parker B; Iskander A
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
Journal of clinical psychopharmacology 2001;21(4):448-53.
2001: Chou J C; Czobor P; Dacpano G; Richardson N; Tuma I; Trujillo M; Cooper T B; Volavka J
Haloperidol blood levels in acute mania with psychosis.
Journal of clinical psychopharmacology 2001;21(4):445-7.
2000: Sheitman B B; Murray M G; Snyder J A; Silva S; Goldman R; Chakos M; Volavka J; Lieberman J A
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness.
Schizophrenia research 2000;46(2-3):203-7.
2000: Nolan K A; Volavka J; Czobor P; Cseh A; Lachman H; Saito T; Tiihonen J; Putkonen A; Hallikainen T; Kotilainen I; Räsänen P; Isohanni M; Järvelin M R; Karvonen M K
Suicidal behavior in patients with schizophrenia is related to COMT polymorphism.
Psychiatric genetics 2000;10(3):117-24.
2000: Nolan K A; Volavka J; Lachman H M; Saito T
An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder.
Psychiatric genetics 2000;10(3):109-15.
2000: Hallikainen T; Lachman H; Saito T; Volavka J; Kauhanen J; Salonen J T; Ryynänen O P; Koulu M; Karvonen M K; Pohjalainen T; Syvälahti E; Hietala J; Tiihonen J
Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior.
American journal of medical genetics 2000;96(3):348-52.
2000: Volavka J; Cooper T B; Czobor P; Lindenmayer J P; Citrome L L; Mohr P; Bark N
High-dose treatment with haloperidol: the effect of dose reduction.
Journal of clinical psychopharmacology 2000;20(2):252-6.
1999: Citrome L; Volavka J
Violent patients in the emergency setting.
The Psychiatric clinics of North America 1999;22(4):789-801.
1999: Chou J C; Czobor P; Charles O; Tuma I; Winsberg B; Allen M H; Trujillo M; Volavka J
Acute mania: haloperidol dose and augmentation with lithium or lorazepam.
Journal of clinical psychopharmacology 1999;19(6):500-5.
1999: Hallikainen T; Saito T; Lachman H M; Volavka J; Pohjalainen T; Ryynänen O P; Kauhanen J; Syvälahti E; Hietala J; Tiihonen J
Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior.
Molecular psychiatry 1999;4(4):385-8.
1999: Nolan K A; Volavka J; Mohr P; Czobor P
Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder.
Psychiatric services (Washington, D.C.) 1999;50(6):787-92.
1999: Tiihonen J; Hallikainen T; Lachman H; Saito T; Volavka J; Kauhanen J; Salonen J T; Ryynänen O P; Koulu M; Karvonen M K; Pohjalainen T; Syvälahti E; Hietala J
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.
Molecular psychiatry 1999;4(3):286-9.
1999: Volavka J
The neurobiology of violence: an update.
The Journal of neuropsychiatry and clinical neurosciences 1999;11(3):307-14.
1998: Lachman H M; Nolan K A; Mohr P; Saito T; Volavka J
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.
The American journal of psychiatry 1998;155(6):835-7.
1997: Volavka J; Laska E; Baker S; Meisner M; Czobor P; Krivelevich I
History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on Determinants of Outcome of Severe Mental Disorders.
The British journal of psychiatry : the journal of mental science 1997;171():9-14.
1997: Krakowski M; Czobor P; Volavka J
Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
Psychiatry research 1997;71(1):19-26.
1997: Strous R D; Bark N; Parsia S S; Volavka J; Lachman H M
Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior.
Psychiatry research 1997;69(2-3):71-7.
1996: Volavka J; Czobor P
Interictal electroencephalographic effects of electroconvulsive therapy. Can they elucidate mechanism of action?
Archives of general psychiatry 1996;53(9):826-7.
1996: Czobor P; Volavka J
Dimensions of the Brief Psychiatric Rating Scale: an examination of stability during haloperidol treatment.
Comprehensive psychiatry 1996;37(3):205-15.
1996: Volavka J; Czobor P; Goodwin D W; Gabrielli W F; Penick E C; Mednick S A; Jensen P; Knop J
The electroencephalogram after alcohol administration in high-risk men and the development of alcohol use disorders 10 years later.
Archives of general psychiatry 1996;53(3):258-63.
1996: Volavka J; Cooper T B; Laska E M; Meisner M
Placebo washout in trials of antipsychotic drugs.
Schizophrenia bulletin 1996;22(4):567-76.
1996: Volavka J; Cooper T B; Czobor P; Meisner M
Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
Psychopharmacology bulletin 1996;32(1):75-9.
1995: Kunz M; Sikora J; Krakowski M; Convit A; Cooper T B; Volavka J
Serotonin in violent patients with schizophrenia.
Psychiatry research 1995;59(1-2):161-3.
1995: Volavka J; Cooper T B; Czobor P; Meisner M
Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder.
Archives of general psychiatry 1995;52(10):837-45.
1995: Czobor P; Volavka J; Meibach R C
Effect of risperidone on hostility in schizophrenia.
Journal of clinical psychopharmacology 1995;15(4):243-9.
1995: Volavka J; Mohammad Y; Vitrai J; Connolly M; Stefanovic M; Ford M
Characteristics of state hospital patients arrested for offenses committed during hospitalization.
Psychiatric services (Washington, D.C.) 1995;46(8):796-800.
1994: Libiger J; Czobor P; Volavka J
Does the change of psychopathology during the placebo period predict the response to subsequent treatment with active medication.
Psychiatry research 1994;52(2):107-14.
1994: Convit A; Volavka J; Czobor P; de Asis J; Evangelista C
Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia.
The American journal of psychiatry 1994;151(1):49-56.
1993: Zito J M; Volavka J; Craig T J; Czobor P; Banks S; Vitrai J
Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia.
The Annals of pharmacotherapy 1993;27(10):1262-9.
1993: Czobor P; Volavka J
Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Journal of clinical psychopharmacology 1993;13(5):332-42.
1993: Volavka J; Zito J M; Vitrai J; Czobar P
Clozapine effects on hostility and aggression in schizophrenia.
Journal of clinical psychopharmacology 1993;13(4):287-9.
1993: Krakowski M I; Kunz M; Czobor P; Volavka J
Long-term high-dose neuroleptic treatment: who gets it and why?
Hospital & community psychiatry 1993;44(7):640-4.
1992: Volavka J; Douyon R; Convit A; Czobor P; Cooper T B
Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
Archives of general psychiatry 1992;49(12):999-1000.
1992: Czobor P; Volavka J
Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve.
Psychiatry research 1992;42(2):129-44.
1992: Volavka J; Convit A; O'Donnell J; Douyon R; Evangelista C; Czobor P
Assessment of risk behaviors for HIV infection among psychiatric inpatients.
Hospital & community psychiatry 1992;43(5):482-5.
1992: Volavka J; Cooper T; Czobor P; Bitter I; Meisner M; Laska E; Gastanaga P; Krakowski M; Chou J C; Crowner M
Haloperidol blood levels and clinical effects.
Archives of general psychiatry 1992;49(5):354-61.
1992: Volavka J
Inhibition of pyruvate dehydrogenase complex by antipsychotic drugs.
Biological psychiatry 1992;31(1):99-102.
1991: Volavka J; Convit A; Czobor P; Douyon R; O'Donnell J; Ventura F
HIV seroprevalence and risk behaviors in psychiatric inpatients.
Psychiatry research 1991;39(2):109-14.
1991: Czobor P; Volavka J
Pretreatment EEG predicts short-term response to haloperidol treatment.
Biological psychiatry 1991;30(9):927-42.
1991: Convit A; Czobor P; Volavka J
Lateralized abnormality in the EEG of persistently violent psychiatric inpatients.
Biological psychiatry 1991;30(4):363-70.
1991: Czobor P; Bitter I; Volavka J
Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.
Psychiatry research 1991;36(2):129-39.
1991: Bitter I; Volavka J; Scheurer J
The concept of the neuroleptic threshold: an update.
Journal of clinical psychopharmacology 1991;11(1):28-33.
1991: Crowner M L; Douyon R; Convit A; Volavka J
Videotape recording of assaults on a state hospital inpatient ward.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(2):S9-14.
1990: Convit A; Isay D; Otis D; Volavka J
Characteristics of repeatedly assaultive psychiatric inpatients.
Hospital & community psychiatry 1990;41(10):1112-5.
1990: Volavka J; Crowner M; Brizer D; Convit A; Van Praag H; Suckow R F
Tryptophan treatment of aggressive psychiatric inpatients.
Biological psychiatry 1990;28(8):728-32.
1990: Jaeger J; Bitter I; Czobor P; Volavka J
The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.
Comprehensive psychiatry 1990;31(3):216-26.
1990: Nemes Z; Volavka J; Bitter I; Laszlo Z
Rhythmic movements of chronic akathisia.
Biological psychiatry 1990;27(4):465-6.
1990: Volavka J; Cooper T B; Meisner M; Bitter I; Czobor P; Jaeger J
Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
Psychopharmacology bulletin 1990;26(1):13-7.
1990: Crowner M L; Douyon R; Convit A; Gaztanaga P; Volavka J; Bakall R
Akathisia and violence.
Psychopharmacology bulletin 1990;26(1):115-7.
1989: Krakowski M I; Convit A; Jaeger J; Lin S; Volavka J
Neurological impairment in violent schizophrenic inpatients.
The American journal of psychiatry 1989;146(7):849-53.
1989: Bitter I; Jaeger J; Agdeppa J; Volavka J
Subjective symptoms: part of the negative syndrome of schizophrenia?
Psychopharmacology bulletin 1989;25(2):180-4.
1988: Pollock V E; Volavka J; Goodwin D W; Gabrielli W F; Mednick S A; Knop J; Schulsinger F
Pattern reversal visual evoked potentials after alcohol administration among men at risk for alcoholism.
Psychiatry research 1988;26(2):191-202.
1988: Pollock V E; Volavka J; Gabrielli W F; Mednick S A; Knop J; Goodwin D W
Pattern reversal visual evoked potential among men at risk for alcoholism.
Acta psychiatrica Scandinavica 1988;78(3):276-82.
1988: Brizer D A; Crowner M L; Convit A; Volavka J
Videotape recording of inpatient assaults: a pilot study.
The American journal of psychiatry 1988;145(6):751-2.
1988: Convit A; Jaeger J; Lin S P; Meisner M; Volavka J
Predicting assaultiveness in psychiatric inpatients: a pilot study.
Hospital & community psychiatry 1988;39(4):429-34.
1988: Krakowski M; Jaeger J; Volavka J
Violence and psychopathology: a longitudinal study.
Comprehensive psychiatry 1988;29(2):174-81.
1988: Volavka J
Can aggressive behavior in humans be modified by beta blockers?
Postgraduate medicine 1988;Spec No():163-8.
1987: Crowner M L; Jaeger J; Convit A; Brizer D; Volavka J
Minor physical anomalies in violent adult inpatients.
Biological psychiatry 1987;22(9):1166-8.
1987: Brizer D A; Convit A; Krakowski M; Volavka J
A rating scale for reporting violence on psychiatric wards.
Hospital & community psychiatry 1987;38(7):769-70.
1986: Krakowski M; Volavka J; Brizer D
Psychopathology and violence: a review of literature.
Comprehensive psychiatry 1986;27(2):131-48.
1983: Pollock V E; Volavka J; Goodwin D W; Mednick S A; Gabrielli W F; Knop J; Schulsinger F
The EEG after alcohol administration in men at risk for alcoholism.
Archives of general psychiatry 1983;40(8):857-61.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jan Volavka

Research Profile (preview)

Disorders

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Procedures

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jan Volavka (preview)

All Publications